| 1. |
Levi M. Disseminated intravascular coagulation[J]. Crit Care Med, 2007, 35(9):2191-2195.
|
| 2. |
Franchini M, Di Minno MN, Coppola A. Disseminated intravascular coagulation in hematologic malignancies[J]. Semin Thromb Hemost, 2010, 36(4):388-403.
|
| 3. |
Tokar M, Bobilev D, Ariad S, et al. Disseminated intravascular coagulation at presentation of advanced gastric cancer[J]. Isr Med Assoc J, 2006, 8(12):853-855.
|
| 4. |
Lin PH, Lu YS, Lin CH, et al. Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation[J]. Anticancer Res, 2010, 30(7):3087-3091.
|
| 5. |
Mizota A, Shitara K, Kondo C, et al. A case of heavily pretreated rectal cancer with disseminated intravascular coagulation that improved following reintroduction of FOLFOX plus bevacizumab[J]. Int J Clin Oncol, 2011, 16(6):766-769.
|
| 6. |
Schlaeppi MR, Korte W, von Moos R, et al. Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanoma[J]. Onkologie, 2006, 29(11):531-533.
|
| 7. |
Green D. Management of bleeding complications of hematologic malignancies[J]. Semin Thromb Hemost, 2007, 33(4):427-434.
|
| 8. |
Dalainas I. Pathogenesis, diagnosis, and management of disseminated intravascular coagulation:a literature review[J]. Eur Rev Med Pharmacol Sci, 2008, 12(1):19-31.
|
| 9. |
Saba HI, Morelli GA. The pathogenesis and management of disseminated intravascular coagulation[J]. Clin Adv Hematol Oncol, 2006, 4(12):919-926.
|
| 10. |
Saba HI, Morelli GA, Saba RI. Disseminated intravascular coagulation (DIC) in cancer[J]. Cancer Treat Res, 2009, 148(2):137-156.
|
| 11. |
Li L, Han DK, Lu J. Interferon-alpha induced severe thrombocytopenia:a case report and review of the literature[J]. World J Gastroenterol, 2010, 16(11):1414-1417.
|
| 12. |
Sakurazawa T, Ohkusa T, Fujimoto H, et al. A case of disseminated intravascular coagulation (DIC) during interferon-alpha treatment of chronic hepatitis C[J]. Nihon Shokakibyo Gakkai zasshi, 1997, 94(6):429-433.
|
| 13. |
Akamatsu S, Asazuma A, Kanamaru S, et al. Immune thrombocytopenia during interferon-alfa therapy for renal cell carcinoma[J]. Hinyokika Kiyo, 2006, 52(10):789-792.
|
| 14. |
Wazny LD, Ariano RE. Evaluation and management of drug-induced thrombocytopenia in the acutely ill patient[J]. Pharmacotherapy, 2000, 20(3):292-307.
|
